The cost-effectiveness of atorvastatin, rosuvastatin and simvastatin in treating patients to LDL-cholesterol targets

被引：0
|
作者：
Niskanen, L. [1 ]
Peura, P. K. [2 ]
Hallinen, T. [2 ]
Soini, E. [2 ]
Martikainen, J. [2 ]
机构：
[1] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland
[2] Univ Kuopio, Dept Social Pharm, FIN-70211 Kuopio, Finland
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：860 / 860
页数：1
相关论文
共 50 条
  • [1] Modelling the cost-effectiveness of statin therapy for treating patients to target LDL-cholesterol
    Maclaine, GDH
    Patel, H
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 : 219 - 219
  • [2] Cost-effectiveness analysis of rosuvastatin compared to atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin
    Benner, JS
    Smith, TW
    Klingman, D
    Tierce, JC
    Mullins, CD
    Pethick, N
    O'Donnell, J
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 323 - 323
  • [3] Cost-effectiveness of atorvastatin, roslivastatin, and simvastatin in reducing LDL-cholesterol to meet the European target level-Bayesian meta-analysis and simulation
    Peura, P.
    Martikainen, J. A.
    Hallinen, T.
    Soini, E. J.
    Niskanen, L.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A416 - A417
  • [4] Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    Ohsfeldt, Robert L.
    Gandhi, Sanjay K.
    Fox, Kathleen M.
    Stacy, Thomas A.
    McKenney, James M.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (15): : S412 - S423
  • [5] An assessment of the efficacy of atorvastatin in treating patients with dyslipidaemia to target LDL-cholesterol goals: The atorvastatin matrix study
    McVey, D
    Patel, H
    Eminton, Z
    Maton, S
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (07) : 509 - 513
  • [6] A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets
    Lachaine, Jean
    Merikle, Elizabeth
    Tarride, Jean-Eric
    Montpetit, Martin
    Rinfret, Stephane
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (03) : 519 - 528
  • [7] Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain
    Cosin Sales, Juan
    Fuentes Jimenez, Francisco Jose
    Mantilla Morato, Teresa
    Ruiz, Emilio
    Becerra, Virginia
    Aceituno, Susana
    Giovanna Ferrario, Maria
    Lizan, Luis
    Gracia, Alfredo
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2015, 27 (05): : 228 - 238
  • [8] Cost effectiveness of Rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with Atorvastatin, Pravastatin, and Simvastatin (a US analysis of the STELLAR trial)
    Miller, PSJ
    Smith, DG
    Jones, P
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (11): : 1314 - 1319
  • [9] MODELED COST-EFFECTIVENESS OF ACHIEVING MULTIPLE LIPID TARGETS WHEN FENOFIBRIC ACID IS CO-ADMINISTERED WITH SIMVASTATIN, ROSUVASTATIN, AND ATORVASTATIN
    Webb, S. F.
    Burge, R. T.
    Sorensen, S., V
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A394 - A394
  • [10] Cost-effectiveness of atorvastatin compared to simvastatin in the Netherlands
    Severens, JL
    Prins, MH
    Monteban, HC
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 671 - 671
12345